Albemarle (ALB) Tops Q2 EPS by 2c, Confirms Outlook
Get Alerts ALB Hot Sheet
Price: $129.57 +2.61%
Revenue Growth %: +19.1%
Financial Fact:
Net income attributable to noncontrolling interests: -9.48M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +19.1%
Financial Fact:
Net income attributable to noncontrolling interests: -9.48M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Albemarle (NYSE: ALB) reported Q2 EPS of $1.13, $0.02 better than the analyst estimate of $1.11. Revenue for the quarter came in at $737.3 million versus the consensus estimate of $736.41 million.
Outlook
Based on our strong performance in the first half of 2017, we confirm our guidance of $2.90 to $3.05 billion in net sales, adjusted EBITDA of $835 to $875 million, and adjusted EPS per diluted share of $4.20 to $4.40.
For earnings history and earnings-related data on Albemarle (ALB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- JPMorgan Upgrades KPJ Healthcare Bhd (KPJ:MK) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share